These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 7531601)

  • 21. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice.
    Wagar EJ; Cromwell MA; Shultz LD; Woda BA; Sullivan JL; Hesselton RM; Greiner DL
    J Immunol; 2000 Jul; 165(1):518-27. PubMed ID: 10861091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. I. T lymphocyte requirement for B cell tumor generation.
    Veronese ML; Veronesi A; D'Andrea E; Del Mistro A; Indraccolo S; Mazza MR; Mion M; Zamarchi R; Menin C; Panozzo M
    J Exp Med; 1992 Dec; 176(6):1763-7. PubMed ID: 1460431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus induced lymphoproliferative tumors in severe combined immunodeficient mice are oligoclonal.
    Pisa P; Cannon MJ; Pisa EK; Cooper NR; Fox RI
    Blood; 1992 Jan; 79(1):173-9. PubMed ID: 1309425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
    Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
    Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
    Ohga S; Ishimura M; Yoshimoto G; Miyamoto T; Takada H; Tanaka T; Ohshima K; Ogawa Y; Imadome K; Abe Y; Akashi K; Hara T
    J Clin Virol; 2011 May; 51(1):31-7. PubMed ID: 21377409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased incidence of EBV-associated lymphoproliferative disorders after allogeneic stem cell transplantation from matched unrelated donors due to a change of T cell depletion technique.
    Meijer E; Slaper-Cortenbach IC; Thijsen SF; Dekker AW; Verdonck LF
    Bone Marrow Transplant; 2002 Feb; 29(4):335-9. PubMed ID: 11896431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo models for Epstein-Barr virus (EBV)-associated B cell lymphoproliferative disease (BLPD).
    Johannessen I; Crawford DH
    Rev Med Virol; 1999; 9(4):263-77. PubMed ID: 10578121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunotherapy for Epstein-Barr virus-associated cancers.
    Rooney CM; Roskrow MA; Smith CA; Brenner MK; Heslop HE
    J Natl Cancer Inst Monogr; 1998; (23):89-93. PubMed ID: 9709309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Central nervous system T-cell lymphoproliferative disorder in a patient with chronic active Epstein-Barr virus infection.
    Ohga S; Takada H; Honda K; Inamura T; Gondo K; Ohshima K; Yamamoto M; Hara T
    J Pediatr Hematol Oncol; 1999; 21(1):42-6. PubMed ID: 10029811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EBV gene expression, EBNA antibody responses and EBV+ peripheral blood lymphocytes in post-transplant lymphoproliferative disease.
    McKnight JL; Cen H; Riddler SA; Breinig MC; Williams PA; Ho M; Joseph PS
    Leuk Lymphoma; 1994 Sep; 15(1-2):9-16. PubMed ID: 7858507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of Epstein-Barr virus-induced human B-cell lymphoma in severe combined immunodeficient mice treated with CD3xCD19 bispecific antibodies, CD28 monospecific antibodies, and autologous T cells.
    Bohlen H; Manzke O; Titzer S; Lorenzen J; Kube D; Engert A; Abken H; Wolf J; Diehl V; Tesch H
    Cancer Res; 1997 May; 57(9):1704-9. PubMed ID: 9135012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management.
    Su IJ; Wang CH; Cheng AL; Chen RL
    Leuk Lymphoma; 1995 Nov; 19(5-6):401-6. PubMed ID: 8590839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human-->mouse radiation chimera do not develop Epstein-Barr virus lymphoma.
    Marcus H; Burakova T; Shezen E; David M; Canaan A; Lubin I; Reisner Y
    Immunol Lett; 1996 Mar; 49(3):155-61. PubMed ID: 8739310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation.
    Lucas KG; Small TN; Heller G; Dupont B; O'Reilly RJ
    Blood; 1996 Mar; 87(6):2594-603. PubMed ID: 8630428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fine-tuning the EBV+ hu-PBL-SCID xenogeneic chimera model using in vivo superinfection.
    Kvell K; Balogh P; Németh P
    Pathol Oncol Res; 2000; 6(4):280-6. PubMed ID: 11173661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The understanding of Epstein-Barr virus associated lymphoproliferative disorder].
    Zhou XG; Zhang YL; Xie JL; Huang YH; Zheng YY; Li WS; Chen H; Liu F; Pan HX; Wei P; Wang Z; Hu YC; Yang KY; Xiao HL; Wu MJ; Yin WH; Mei KY; Chen G; Yan XC; Meng G; Xu G; Li J; Tian SF; Zhu J; Song YQ; Zhang WJ
    Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):817-821. PubMed ID: 28056294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
    Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
    Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-correlation of in vivo and in vitro parameters of Epstein-Barr virus persistence suggests heterogeneity of B cell infection.
    Johannessen I; Haque T; N'Jie-Jobe J; Crawford DH
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1631-6. PubMed ID: 9680124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunologic monitoring after organ transplantation: relationship between Epstein-Barr virus infection and CD19+ B cells measured by flow cytometry.
    Morrissey PE; Lorber KM; Marcarelli M; Bia MJ; Kliger AS; Lorber MI
    Transplant Proc; 1995 Feb; 27(1):1428-30. PubMed ID: 7533384
    [No Abstract]   [Full Text] [Related]  

  • 40. Analysis of the T-cell micro-environment in Epstein-Barr virus-related post-transplantation B lymphoproliferative disease.
    Perera SM; Thomas JA; Burke M; Crawford DH
    J Pathol; 1998 Feb; 184(2):177-84. PubMed ID: 9602709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.